Literature DB >> 10440363

Rebuilding the road to cancer.

J B Weitzman, M Yaniv.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440363     DOI: 10.1038/22637

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Use of human tissue to assess the oncogenic activity of melanoma-associated mutations.

Authors:  Yakov Chudnovsky; Amy E Adams; Paul B Robbins; Qun Lin; Paul A Khavari
Journal:  Nat Genet       Date:  2005-06-12       Impact factor: 38.330

2.  Progressive transformation of immortalized esophageal epithelial cells.

Authors:  Zhong-Ying Shen; Li-Yan Xu; Min-Hua Chen; Jian Shen; Wei-Jia Cai; Yi Zeng
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

3.  Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes.

Authors:  E González-Suárez; E Samper; A Ramírez; J M Flores; J Martín-Caballero; J L Jorcano; M A Blasco
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

Review 4.  K-Ras mutations and benign pancreatic disease.

Authors:  M Löhr; P Maisonneuve; A B Lowenfels
Journal:  Int J Pancreatol       Date:  2000-04

5.  Cyclo[n]pyrroles: size and site-specific binding to G-quadruplexes.

Authors:  Erin Shammel Baker; Jeong Tae Lee; Jonathan L Sessler; Michael T Bowers
Journal:  J Am Chem Soc       Date:  2006-03-01       Impact factor: 15.419

6.  Canis familiaris telomerase reverse transcriptase undergoes alternative splicing.

Authors:  Katerina Angelopoulou; Michael Zavlaris; Nikolaos Papaioannou; Ioannis Vlemmas
Journal:  Mamm Genome       Date:  2008-10-04       Impact factor: 2.957

7.  Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy.

Authors:  R Li; A Sonik; R Stindl; D Rasnick; P Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.